pyronaridine has been researched along with Malaria, Falciparum in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (25.00) | 18.2507 |
2000's | 8 (14.29) | 29.6817 |
2010's | 27 (48.21) | 24.3611 |
2020's | 7 (12.50) | 2.80 |
Authors | Studies |
---|---|
Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA | 1 |
Avery, VM; Dans, MG; de Koning-Ward, TF; Duffy, S; Gancheva, MR; Gilson, PR; Lowes, KN; Ngo, A; Nguyen, W; Romeo, O; Sabroux, HJ; Sleebs, BE; Wilson, DW | 1 |
Avery, VM; Challis, MP; Creek, DJ; De Paoli, A; Devine, SM; Kigotho, JK; MacRaild, CA; Norton, RS; Scammells, PJ; Siddiqui, G | 1 |
Chu, WY; Dorlo, TPC | 1 |
Badolo, L; Dhingra, SK; Fidock, DA; Giddins, MJ; Greco, B; Gumpp, C; Jonat, B; Oeuvray, C; Rottmann, M; Spangenberg, T; Yin, X | 1 |
Bailly, C | 1 |
Clark, RL | 1 |
Mahotorn, K; Mungthin, M; Ruang-Areerate, T; Sittichot, N; Suwandittakul, N; Tan-Ariya, P; Thita, T | 1 |
Choy, F; Makio, N; Mens, P; Okach, S; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
Bousema, T; Bradley, J; Makio, N; Mens, PF; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
Hine, P; Pryce, J | 1 |
Fidock, DA; Okombo, J | 1 |
Bustos, MD; Cong Tran, D; Hong Huynh, Q; Khim, N; Quang Bui, P; Quang Nguyen, T; Ringwald, P; Thanh Le, D; Thanh Tran, D; Thi Ta, T; Van Truong, H; Witkowski, B | 1 |
Arbe-Barnes, S; Borghini-Fuhrer, I; Craft, CJ; Duparc, S; Fleckenstein, L; Miller, RM; Shin, CS | 1 |
Arzika, I; Fandeur, T; Guillebaud, J; Issaka, M; Maazou, A; Salissou, A; Specht, S; Zamanka, H | 1 |
Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
Cui, L; Gupta, B; Miao, J; Sun, L; Wang, Z; Xu, S; Yang, Z | 1 |
Ashley, EA; Blessborn, D; Chairat, K; Day, NP; Hanboonkunupakarn, B; Jittamala, P; Lee, SJ; Nosten, F; Panapipat, S; Pukrittayakamee, S; Tarning, J; Thana, P; White, NJ | 1 |
Amalvict, R; Benoit, N; Briolant, S; Gaillard, T; Madamet, M; Pascual, A; Pradines, B; Travers, D | 1 |
Ayyoub, A; Borghini-Fuhrer, I; Djimde, AA; Duparc, S; Fleckenstein, L; Methaneethorn, J; Ramharter, M; Shin, JS; Tekete, M | 1 |
Borghini Fuhrer, I; Canavati, SE; Denis, MB; Dondorp, AM; Duparc, S; Heng, P; Huy, R; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Tol, B; Vestergaard, LS | 1 |
Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Bélard, S; Cisse, B; Fleckenstein, L; Glasenapp, Iv; Issifou, S; Kammer, J; Koumba, PK; Kremsner, PG; Kurth, F; Lell, B; Mordmüller, B; Nemeth, J; Oeuvray, C; Ramharter, M; Schlie, M; Schreier, AC | 1 |
Bélard, S; Kremsner, PG; Kurth, F; Mordmüller, B; Pongratz, P; Ramharter, M | 1 |
Nosten, FH | 1 |
Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
Nau, JY | 1 |
Basra, A; Bélard, S; Kurth, F; Ramharter, M | 1 |
Kiara, SM; Mwai, L; Nzila, A; Ochola, LI; Ohuma, E; Okombo, J; Pole, L | 1 |
Abdulla, S; Binh, TQ; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Pénali, LK; Phyo, AP; Poravuth, Y; Rueangweerayut, R; Shin, CS; Tien, NT; Tinto, H; Uthaisin, C; Valecha, N | 1 |
Arbe-Barnes, SJ; Borghini-Fuhrer, I; Craft, JC; Croft, SL; Duparc, S; Fleckenstein, L; Rim, HJ; Shin, CS | 1 |
Liu, H; Wang, J; Zhang, CL; Zhou, HN | 1 |
Holtermann, MK | 1 |
Bhatt, KM; Borghini-Fuhrer, I; Bustos, MD; de Salazar, PM; Doumbo, OK; Duparc, S; Fleckenstein, L; Kayentao, K; Kimani, J; Kokolomami, JH; Offianan, AT; Ouédraogo, A; Pénali, LK; Quicho, F; Ramharter, M; Shin, CS; Tiono, AB; Tshefu, AK | 1 |
Agnamey, P; Brasseur, P; Galega, PF; Moyou, SR | 1 |
Chen, C; Chen, PL; Chen, WJ; Feng, XP; Lin, SG; Liu, DQ; Liu, J; Wu, HM | 1 |
Feng, XP; Liu, DQ | 1 |
Karupiah, S; Mansor, SM; Nair, NK; Navaratnam, V; Olliaro, PL; Ramanathan, S; Wernsdorfer, WH | 1 |
Feng, XP; Liu, DQ; Liu, RJ; Zhang, CY | 1 |
Winstanley, P | 1 |
Basco, L; Bickii, J; Ringwald, P | 1 |
Peters, W | 1 |
Kyle, D; Looareesuwan, S; Olliaro, P; Wernsdorfer, W | 1 |
Foster, S | 1 |
Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wernsdorfer, WH; Wilairatana, P | 1 |
Chang, C; Kano, S; Kawai, S; Suzuki, M | 1 |
Basco, LK; Bickii, J; Ringwald, P | 1 |
Doury, JC; Kombila, M; Lebeau, C; Mabika Mamfoumbi, M; Mourou Mbina, JR; Owono Medang, M; Parzy, D; Pradines, B | 1 |
Basco, LK; Meche, FS; Ringwald, P | 1 |
Basco, LK; Ringwald, P | 1 |
Auparakkitanon, S; Chavalitshewinkoon-Petmitr, P; Pongvilairat, G; Wilairat, P | 1 |
Huang, K; Li, C; Liu, D; Yang, H; Zhang, C | 1 |
Fan, B; Huang, Z; Ma, X; Wen, Y; Yang, J; Yang, Z; Zhao, W | 1 |
Chen, C; Zheng, X | 1 |
8 review(s) available for pyronaridine and Malaria, Falciparum
Article | Year |
---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.
Topics: Antimalarials; Child; Chloroquine; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy | 2023 |
Pyronaridine: An update of its pharmacological activities and mechanisms of action.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum | 2021 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2019 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
Pyronaridine-artesunate combination therapy for the treatment of malaria.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Malaria, Vivax; Naphthyridines | 2011 |
Development of the new antimalarial drug pyronaridine: a review.
Topics: Administration, Oral; Animals; Antimalarials; Cardiovascular System; Chloroquine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Haplorhini; Humans; Injections, Intramuscular; Lethal Dose 50; Malaria, Falciparum; Mice; Naphthyridines; Pyrimethamine; Rabbits; Sulfadoxine | 1992 |
16 trial(s) available for pyronaridine and Malaria, Falciparum
Article | Year |
---|---|
Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines | 2018 |
Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Reverse Transcriptase Polymerase Chain Reaction; Self-Sustained Sequence Replication | 2018 |
Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Prospective Studies; Vietnam | 2020 |
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Primaquine; Thailand; Young Adult | 2015 |
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Topics: Adolescent; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Models, Theoretical; Naphthyridines | 2015 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthyridines; Proportional Hazards Models; Young Adult | 2012 |
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dosage Forms; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasite Load; Recurrence; Tablets; Treatment Outcome | 2012 |
[Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine].
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Middle Aged; Naphthyridines; Sesquiterpenes | 2002 |
A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma.
Topics: Administration, Oral; Antimalarials; Area Under Curve; Calibration; Chromatography, Liquid; Half-Life; Humans; Malaria, Falciparum; Naphthyridines; Regression Analysis; Reproducibility of Results; Time Factors | 2005 |
Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Cameroon; Chloroquine; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Plasmodium falciparum; Treatment Outcome | 1996 |
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthyridines | 1996 |
Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children.
Topics: Administration, Oral; Adolescent; Antimalarials; Blood Cell Count; Cameroon; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Naphthyridines | 1998 |
Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Naphthyridines; Parasitemia; Plasmodium falciparum | 1999 |
Molecular epidemiology of malaria in Yaounde, Cameroon V. analysis of the omega repetitive region of the plasmodium falciparum CG2 gene and chloroquine resistance.
Topics: Adolescent; Adult; Animals; Antimalarials; Cameroon; Child; Chloroquine; DNA Primers; DNA, Protozoan; Drug Resistance; Electrophoresis, Agar Gel; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Naphthyridines; Parasitemia; Phenanthrenes; Plasmodium falciparum; Polymerase Chain Reaction; Regression Analysis; Repetitive Sequences, Nucleic Acid; Scintillation Counting; Sequence Analysis, DNA | 1999 |
Development of the new antimalarial drug pyronaridine: a review.
Topics: Administration, Oral; Animals; Antimalarials; Cardiovascular System; Chloroquine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Haplorhini; Humans; Injections, Intramuscular; Lethal Dose 50; Malaria, Falciparum; Mice; Naphthyridines; Pyrimethamine; Rabbits; Sulfadoxine | 1992 |
33 other study(ies) available for pyronaridine and Malaria, Falciparum
Article | Year |
---|---|
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins | 2018 |
Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
Topics: Animals; Antimalarials; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Erythrocytes; Hep G2 Cells; Humans; Malaria, Falciparum; Mice; Microsomes, Liver; Molecular Structure; Parasitic Sensitivity Tests; Piperazines; Plasmodium falciparum; Plasmodium knowlesi; Solubility; Structure-Activity Relationship | 2021 |
Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Topics: Antimalarials; Benzimidazoles; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
Topics: Animals; Antimalarials; Drug Resistance; Drug Therapy, Combination; Hemeproteins; Malaria, Falciparum; Mice; Mice, SCID; Naphthyridines; Peptide Elongation Factor 2; Plasmodium falciparum; Quinolines | 2020 |
In Vitro Sensitivity of Pyronaridine in Thai Isolates of
Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple; Genes, Protozoan; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand | 2018 |
Pyronaridine-artesunate Shows Promise as an Effective and Well-tolerated Treatment for Artemisinin-resistant Plasmodium falciparum Malaria.
Topics: Artemisinins; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Vietnam | 2020 |
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2013 |
Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines; Niger; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2013 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.
Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Geography; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Selection, Genetic; Sequence Analysis, DNA | 2014 |
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.
Topics: Africa; Antimalarials; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Quinolines | 2015 |
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Young Adult | 2016 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Gabon; Humans; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Polymerase Chain Reaction; Safety; Treatment Outcome | 2008 |
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
Topics: Administration, Oral; Adolescent; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Biological Assay; Child; Child, Preschool; Chloroquine; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinine; Regression Analysis | 2009 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
[A new antimalarial drug combination].
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Treatment Outcome | 2010 |
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.
Topics: Animals; Antimalarials; Humans; Kenya; Malaria, Falciparum; Methylene Blue; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2012 |
Review of pyronaridine anti-malarial properties and product characteristics.
Topics: Antimalarials; China; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria, Falciparum; Malaria, Vivax; Naphthyridines; Plasmodium falciparum; Plasmodium vivax; Treatment Outcome | 2012 |
[In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; China; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Myanmar; Naphthyridines; Plasmodium falciparum; Quinolines; Young Adult | 2012 |
[New combination therapy against malaria].
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug Combinations; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Mefloquine; Naphthyridines | 2012 |
[Center of multidrug-resistant malaria in a forest zone of Cameroon revisited after 14 years].
Topics: Amodiaquine; Animals; Cameroon; Chloroquine; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Quinine; Trees | 2002 |
[Factors affecting the in vitro microtest for drug sensitivity of Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood; Chloroquine; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2003 |
[Establishment of in vitro microtest for determining sensitivity of Plasmodium falciparum to pyronaridine].
Topics: Animals; Antimalarials; China; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Treatment Outcome | 2006 |
Pyronaridine: a promising drug for Africa?
Topics: Africa; Antimalarials; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Naphthyridines | 1996 |
Pyronaridine against multiresistant falciparum malaria.
Topics: Antimalarials; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Naphthyridines | 1996 |
Pyronaridine.
Topics: Adult; Antimalarials; Cameroon; Clinical Trials as Topic; Humans; Malaria, Falciparum; Naphthyridines; Thailand | 1996 |
Pyronaridine.
Topics: Antimalarials; Humans; Malaria, Falciparum; Naphthyridines | 1996 |
The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus.
Topics: Animals; Antimalarials; Aotus trivirgatus; Female; Malaria, Falciparum; Microscopy, Electron; Naphthyridines; Parasitemia; Plasmodium falciparum; Vacuoles | 1996 |
In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Gabon; Humans; Infant; Malaria, Falciparum; Naphthyridines; Phenanthrenes; Plasmodium falciparum; Quinine | 1999 |
Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.
Topics: Amsacrine; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Naphthyridines; Norfloxacin; Nucleic Acid Synthesis Inhibitors; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Thailand; Topoisomerase II Inhibitors; Triazines | 2000 |
[Longitudinal surveillance of sensitivity of Plasmodium falciparum to pyronaridine in south Yunnan].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Middle Aged; Naphthyridines; Plasmodium falciparum; Recurrence; Sensitivity and Specificity | 1998 |
[In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1998 |